Dhampur Bio Organics Ltd

Dhampur Bio Organics Ltd

$DBOLSugarNSEBSE

Dhampur Bio Organics Ltd (DBOL) last traded at ₹128, a market capitalisation of ₹852 crore, on a P/E of 33.3. Over the past 52 weeks the stock has ranged between ₹69 and ₹139. Dhampur Bio Organics Ltd last reported results for the quarter ended Jun 2026, with sales of ₹533 crore and net profit of ₹37 crore. Figures are as of 25 Aug 2026 and are not real time.

Dhampur Bio Organics Ltd share price and key metrics

Current price
₹128
Market cap
₹852 cr
Stock P/E
33.3
Book value
₹155
ROE
2.61%
ROCE
4.98%
Dividend yield
1.16%
52w high / low
139/69.0

Metrics as of 25 Aug 2026. Not real time.

Dhampur Bio Organics Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹533 cr, up 8.3% from ₹492 cr a year earlier. Net profit turned positive at ₹37 cr.

Dhampur Bio Organics Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales466464464492558486460533
Expenses476448369484566444380524
Operating profit-1016969-843809
OPM %-2.1%3.4%21%1.8%-1.4%9%17%1.7%
Other income1-11-61391552
Interest1610201914111416
Depreciation1115161215151313
Profit before tax-35-1061-29-23266932
Tax %-34%-32%26%-24%-32%34%33%-14%
Net profit-23-745-22-16174637
EPS (₹)-3.52-1.036.75-3.31-2.412.556.975.54

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Dhampur Bio Organics Ltd annual results

Dhampur Bio Organics Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales01,5642,4081,8641,8622,1092,036
Operating profit-0183205140135133124
OPM %12%8%8%7%6%6%
Net profit-010211146152584
EPS (₹)16.747.002.213.7912.65

TTM is the trailing twelve months to the most recent quarter.

Dhampur Bio Organics Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
%
3 Years
-4%
TTM
8%
Compounded Profit Growth
10 Years
%
5 Years
384%
3 Years
-38%
TTM
1042%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
-6%
1 Year
50%
Return on Equity
10 Years
%
5 Years
6%
3 Years
3%
Last Year
3%

Dhampur Bio Organics Ltd shareholding pattern

Promoters held 50.78% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.29% and DIIs 0.82%.

Dhampur Bio Organics Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters50.79%50.79%50.79%50.79%50.65%50.65%50.65%50.78%
FIIs0.83%0.66%0.54%0.43%0.35%0.45%0.54%0.29%
DIIs1.35%0.45%0.45%0.45%0.45%0.79%0.79%0.82%
Public47.04%48.10%48.23%48.33%47.67%47.22%47.11%47.08%
No. of shareholders50,56350,26349,69049,00548,05546,61745,14944,537

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Dhampur Bio Organics Ltd corporate filings

  • Intimation of Payment of Final Dividend for the Financial Year 2025-26Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Dhampur Bio Organics Ltd. has formally intimated the completion of the final dividend…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sonitron LtdInsider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: Dhampur Bio Organics Limited has disclosed that its promoter group entity, Sonitron…

    Read the full analysis
  • The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sonitron LtdInsider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: Sonitron Limited, a promoter group entity, has increased its shareholding in Dhampur Bio…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Dhampur Bio Organics Ltd

Cruxal reads every Dhampur Bio Organics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.